Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

144 public trials 33 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

NCT01471782

Conditions
Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +23 more
Locations
  • Children's Hospital Denver Aurora, Colorado, United States
  • Children's Healthcare of Atlanta at Egleston Atlanta, Georgia, United States
  • Washington University St Louis, Missouri, United States
  • Memorial Sloan Kettering New York, United States
View all 30 locations
View Trial Details
Completed

Clinical Study With Blinatumomab in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)

NCT01741792

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Universitätsmedizin Göttingen, Germany
  • Universitätsklinikum des Saarlandes Homburg, Germany
  • Universitätsklinikum Schleswig Holstein Kiel, Germany
  • Klinikum der Johannes-Gutenberg Universität Mainz, Germany
View Trial Details
Completed

Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer

NCT00053053

Conditions
Body Weight, Body Weight Changes, Burkitt Lymphoma, +44 more
Locations
  • Comprehensive Cancer Center at University of Alabama at Birmingham Birmingham, Alabama, United States
  • Comprehensive Cancer Institute Huntsville, Alabama, United States
  • MBCCOP - Gulf Coast Mobile, Alabama, United States
  • Montgomery Cancer Center Montgomery, Alabama, United States
View all 250 locations
View Trial Details
Completed

Epoetin Alfa in Treating Anemia in Patients With Solid Tumors

NCT00058331

Conditions
Anemia, Blood Protein Disorders, Cardiovascular Diseases, +21 more
Locations
  • CCOP - Mayo Clinic Scottsdale Oncology Program Scottsdale, Arizona, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • CCOP - Illinois Oncology Research Association Peoria, Illinois, United States
  • CCOP - Carle Cancer Center Urbana, Illinois, United States
View all 18 locations
View Trial Details
Completed

Study of RAD001 in Patients With Relapsed/Refractory Hodgkin Lymphoma That Has Progressed After High-dose Chemotherapy and Autologous Stem Cell Transplant and/or After Gemcitabine- or Vinorelbine- or Vinblastine-based Treatment.

NCT01022996

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations
  • University of California at Los Angeles UCLS School of Medicine Los Angeles, California, United States
  • Rocky Mountain Cancer Centers RMCC - Aurora Greenwood Village, Colorado, United States
  • MD Anderson Cancer Center - Orlando Orlando, Florida, United States
  • Emory University School of Medicine/Winship Cancer Institute Emory University Med School Atlanta, Georgia, United States
View all 16 locations
View Trial Details
Completed

Study of SGN-40 in Patients With Relapsed Diffuse Large B-Cell Lymphoma

NCT00435916

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic-Arizona Scottsdale, Arizona, United States
  • University of California Los Angeles Los Angeles, California, United States
  • Stanford University Medical Center Palo Alto, California, United States
View all 14 locations
View Trial Details
Completed

Trial to Define the Safety and Tolerability of SGN-40, Rituximab, and Gemcitabine in Patients With DLBCL

NCT00655837

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • University of Colorado Aurora, Colorado, United States
  • Oncology Specialists Park Ridge, Illinois, United States
View Trial Details

Related conditions